363 related articles for article (PubMed ID: 9261358)
21. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
de Parseval A; Elder JH
J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
[TBL] [Abstract][Full Text] [Related]
22. Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus.
Hu QY; Fink E; Grant CK; Elder JH
PLoS One; 2014; 9(12):e115252. PubMed ID: 25521480
[TBL] [Abstract][Full Text] [Related]
23. Adaptation of feline immunodeficiency virus subtype B strain TM2 to a feline astrocyte cell line (G355-5 cells).
Ishikawa M; Baba K; Shimojima M; Okada M; Shojima T; Miura T; Miyazawa T
Vet Microbiol; 2011 May; 149(3-4):307-15. PubMed ID: 21168982
[TBL] [Abstract][Full Text] [Related]
24. Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.
Zhang Z; Gu Q; Jaguva Vasudevan AA; Hain A; Kloke BP; Hasheminasab S; Mulnaes D; Sato K; Cichutek K; Häussinger D; Bravo IG; Smits SH; Gohlke H; Münk C
Retrovirology; 2016 Jul; 13(1):46. PubMed ID: 27368163
[TBL] [Abstract][Full Text] [Related]
25. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
[TBL] [Abstract][Full Text] [Related]
26. Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.
Hu QY; Fink E; Hong Y; Wang C; Grant CK; Elder JH
PLoS One; 2010 May; 5(5):e10689. PubMed ID: 20502526
[TBL] [Abstract][Full Text] [Related]
27. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.
Willett BJ; McMonagle EL; Logan N; Samman A; Hosie MJ
Retrovirology; 2008 Aug; 5():77. PubMed ID: 18721458
[TBL] [Abstract][Full Text] [Related]
28. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
[TBL] [Abstract][Full Text] [Related]
29. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
Matsuda S; Miyata M
Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
[TBL] [Abstract][Full Text] [Related]
30. Differential CXCR4 expression and function in subpopulations of the feline lymphoma cell line 3201 susceptible to feline immunodeficiency virus.
Tochikura TS; Motokawa K; Naito Y; Kozutsumi Y; Tanabe-Tochikura A; Hohdatsu T
J Feline Med Surg; 2010 Apr; 12(4):269-77. PubMed ID: 19896878
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats.
Scott VL; Burgess SC; Shack LA; Lockett NN; Coats KS
Vet Immunol Immunopathol; 2008 May; 123(1-2):90-6. PubMed ID: 18295905
[TBL] [Abstract][Full Text] [Related]
32. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
Chabot DJ; Zhang PF; Quinnan GV; Broder CC
J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
[TBL] [Abstract][Full Text] [Related]
33. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
de Parseval A; Ngo S; Sun P; Elder JH
J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
[TBL] [Abstract][Full Text] [Related]
34. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence.
Hohdatsu T; Hirabayashi H; Motokawa K; Koyama H
J Gen Virol; 1996 Jan; 77 ( Pt 1)():93-100. PubMed ID: 8558132
[TBL] [Abstract][Full Text] [Related]
36. Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.
Lerner DL; Elder JH
J Virol; 2000 Feb; 74(4):1854-63. PubMed ID: 10644358
[TBL] [Abstract][Full Text] [Related]
37. Expression of CXCR4 in the brain of feline immunodeficiency virus infected cat.
Koirala TR; Sharma S; Morikawa S; Ishida T
Indian J Pathol Microbiol; 2000 Jul; 43(3):285-90. PubMed ID: 11218674
[TBL] [Abstract][Full Text] [Related]
38. Expression cloning of new receptors used by simian and human immunodeficiency viruses.
Deng HK; Unutmaz D; KewalRamani VN; Littman DR
Nature; 1997 Jul; 388(6639):296-300. PubMed ID: 9230441
[TBL] [Abstract][Full Text] [Related]
39. Use of CD134 as a primary receptor by the feline immunodeficiency virus.
Shimojima M; Miyazawa T; Ikeda Y; McMonagle EL; Haining H; Akashi H; Takeuchi Y; Hosie MJ; Willett BJ
Science; 2004 Feb; 303(5661):1192-5. PubMed ID: 14976315
[TBL] [Abstract][Full Text] [Related]
40. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.
Pancino G; Camoin L; Sonigo P
J Virol; 1995 Apr; 69(4):2110-8. PubMed ID: 7884857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
